The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DAVE INC | CLASS A COM NEW | 23834J201 | 23,283,693 | 582,675 | SH | SOLE | 582,675 | 0 | 0 | ||
DIGITAL BRANDS GROUP INC | COM NEW | 25401N408 | 214 | 636 | SH | SOLE | 636 | 0 | 0 | ||
GROVE COLLABORATIVE HOLD INC | COM CL A | 39957D201 | 3,973,755 | 2,943,522 | SH | SOLE | 2,943,522 | 0 | 0 | ||
MBX BIOSCIENCES INC | COM | 55287L101 | 55,501,983 | 2,136,335 | SH | SOLE | 2,136,335 | 0 | 0 | ||
OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 8,379,124 | 4,189,562 | SH | SOLE | 4,189,562 | 0 | 0 | ||
TALKSPACE INC | COM | 87427V103 | 30,729,211 | 14,702,972 | SH | SOLE | 14,702,972 | 0 | 0 | ||
UDEMY INC | COM | 902685106 | 23,173,606 | 3,114,732 | SH | SOLE | 3,114,732 | 0 | 0 | ||
ZENAS BIOPHARMA INC | COM | 98937L105 | 31,107,115 | 1,838,482 | SH | SOLE | 1,838,482 | 0 | 0 |